DE2630394A1 - Oxazepine enthaltende arzneimittel mit verzoegerter wirkstofffreisetzung - Google Patents

Oxazepine enthaltende arzneimittel mit verzoegerter wirkstofffreisetzung

Info

Publication number
DE2630394A1
DE2630394A1 DE19762630394 DE2630394A DE2630394A1 DE 2630394 A1 DE2630394 A1 DE 2630394A1 DE 19762630394 DE19762630394 DE 19762630394 DE 2630394 A DE2630394 A DE 2630394A DE 2630394 A1 DE2630394 A1 DE 2630394A1
Authority
DE
Germany
Prior art keywords
chloro
dibenz
piperazinyl
suspension
oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19762630394
Other languages
German (de)
English (en)
Inventor
James Elwood Krueger
Arnold Curtis Osterberg
George Madison Sieger
David Henry Tedeschi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of DE2630394A1 publication Critical patent/DE2630394A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DE19762630394 1975-07-16 1976-07-06 Oxazepine enthaltende arzneimittel mit verzoegerter wirkstofffreisetzung Withdrawn DE2630394A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/596,488 US4016273A (en) 1975-07-16 1975-07-16 Sustained release forms of certain oxazepines for parenteral administration

Publications (1)

Publication Number Publication Date
DE2630394A1 true DE2630394A1 (de) 1977-02-03

Family

ID=24387483

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762630394 Withdrawn DE2630394A1 (de) 1975-07-16 1976-07-06 Oxazepine enthaltende arzneimittel mit verzoegerter wirkstofffreisetzung

Country Status (11)

Country Link
US (1) US4016273A (https=)
BE (1) BE844203A (https=)
CA (1) CA1062159A (https=)
DE (1) DE2630394A1 (https=)
DK (1) DK319776A (https=)
FI (1) FI762053A7 (https=)
FR (1) FR2317912A1 (https=)
GB (1) GB1525425A (https=)
NL (1) NL7607918A (https=)
PT (1) PT65358B (https=)
SE (1) SE7608114L (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6617321B2 (en) * 1997-09-30 2003-09-09 Eli Lilly And Company 2-methyl-thieno-benzodiazepine formulation
US6199634B1 (en) 1998-08-27 2001-03-13 Viatchelav Ivanovich Selyakov Method and apparatus for controlling the permeability of mineral bearing earth formations
JP4361710B2 (ja) * 2000-04-19 2009-11-11 ジェネンテック・インコーポレーテッド 徐放製剤
WO2002013870A2 (en) * 2000-08-17 2002-02-21 Mitokor, Inc. Formulation for administering therapeutic lipophilic molecules
DE10059020A1 (de) * 2000-11-28 2002-05-29 Gruenenthal Gmbh Parenteral applizierbare Darreichungsformen
AU2002320122B2 (en) * 2001-06-21 2007-07-26 Genentech, Inc. Sustained release formulation
US6972195B2 (en) * 2002-09-27 2005-12-06 Rongxiang Xu Composition and method for culturing potentially regenerative cells and functional tissue-organs in vitro
US6685971B2 (en) * 2001-06-28 2004-02-03 Rongxiang Xu Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract
CN1827766B (zh) * 2001-06-28 2010-08-25 徐荣祥 体外细胞的培养方法
BRPI0418304A (pt) * 2004-01-07 2007-05-02 Trimeris Inc peptìdeo sintético, uso do mesmo, composição farmacêutica, seqüência de nucleotìdeos, e, métodos para inibição da transmissão de hiv para uma célula, para inibição da fusão de hiv, e para tratamento de um indivìduo infectado com hiv
PL1838716T3 (pl) * 2005-01-05 2011-09-30 Lilly Co Eli Dihydrat embonianu olanzapiny
US7456251B2 (en) * 2006-02-02 2008-11-25 Trimeris, Inc. HIV fusion inhibitor peptides with improved biological properties
ES2346005T3 (es) * 2006-07-27 2010-10-07 Cognis Ip Management Gmbh Procedimiento para la obtencion de glicerina.
BRPI0809995A2 (pt) * 2007-04-03 2015-07-21 Trimeris Inc Composição, e, métodos para a liberação prolongada de um peptídeo em um paciente e para melhorar um sintoma associado com uma infecção por hiv
KR20100080812A (ko) * 2007-09-25 2010-07-12 트라이머리스, 인코퍼레이티드 치료용 항-ｈｉｖ 펩티드의 합성 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3116203A (en) * 1962-03-14 1963-12-31 Hoffmann La Roche Oleaginous systems
US3164520A (en) * 1962-10-29 1965-01-05 Olin Mathieson Injectable steroid compositions containing at least 75% benzyl benzoate
NL140242B (nl) * 1963-03-01 1973-11-15 Wander Ag Dr A Werkwijze voor het bereiden van op de 11-plaats door een basische groep gesubstitueerde dibenz (b.f.)(1.4) oxazepinen.
US3538216A (en) * 1964-02-20 1970-11-03 Lab De Rech Physiques S A R L Injectable compositions of a drug suspended in an emulsion
GB1192812A (en) * 1966-05-20 1970-05-20 American Cyanamid Co 2-Chloro-11-(1-Piperazinyl)Dibenz[b,f]-[1,4]Oxazepine, Non-Toxic Acid Addition Salts thereof, and Therapeutic Compositions containing said Oxazepine or Salts
US3546220A (en) * 1966-08-01 1970-12-08 Abbott Lab 2,3-dihydro-1h-pyrido-(2,3-b)(1,4)thiazines
US3549621A (en) * 1968-04-29 1970-12-22 Harry Louis Yale 12-substituted-6h-dibenz(b,f)(1,4)oxazocin-11(12h) ones
US3891647A (en) * 1970-08-06 1975-06-24 Wander Ag Dr A 2-trifluoromethyl-sulphonyl-11-substituted-piperazinyl-dibenz {8 b,f{9 {8 1,4{9 {0 oxazepine
US3773768A (en) * 1970-10-26 1973-11-20 American Cyanamid Co 7-amino-2-chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine and salts thereof

Also Published As

Publication number Publication date
BE844203A (fr) 1977-01-17
PT65358B (en) 1978-01-09
PT65358A (en) 1976-08-01
SE7608114L (sv) 1977-01-17
NL7607918A (nl) 1977-01-18
US4016273A (en) 1977-04-05
FR2317912B1 (https=) 1979-04-13
CA1062159A (en) 1979-09-11
DK319776A (da) 1977-01-17
FI762053A7 (https=) 1977-01-17
FR2317912A1 (fr) 1977-02-11
GB1525425A (en) 1978-09-20

Similar Documents

Publication Publication Date Title
DE2630394A1 (de) Oxazepine enthaltende arzneimittel mit verzoegerter wirkstofffreisetzung
DE60019693T2 (de) Pharmazeutische zusammensetzungen, die wirkstoffabsorptionsfördernde verbindungen enthalten
DE68928920T2 (de) Fettsäure-arzneimittel-konjugat zur verabreichung von arzneimitteln durch die blut-gehirn-schranke
US3164520A (en) Injectable steroid compositions containing at least 75% benzyl benzoate
DE2635476C2 (de) Tierarzneimittel
EP0254902B1 (de) Lösungen von Oxazaphosphorinen mit verbesserter Stabilität und Verfahren zu deren Herstellung
CH643456A5 (de) Pharmazeutische zubereitung.
EP0130524A2 (de) Depot-Antiphlogistika
CH643738A5 (en) Highly concentrated pharmaceutical steroid products
DE60036639T2 (de) Verwendung von sumsoo-extrakt in pharmazeutischen verbindungen zur prävention und behandlung erektiler impotenz
DE3884945T2 (de) Emulsion für parenterale verabreichung.
DE2310770A1 (de) Penicillinverbindungen enthaltende pharmazeutische zubereitungen
DE69624935T2 (de) Orale gelkapselformulierung von 1,2,4- benzotriazinoxiden
EP1850830B1 (de) Suppositorium zur bindung von reaktiven sauerstoffverbindungen im körper von menschen und tieren
JPH0570609B2 (https=)
DE2633891C2 (de) Tris-(hydroxymethyl)-aminomethansalz der 2-(5-Benzoylthienyl)-α-methylessigsäure, Verfahren zu dessen Herstellung und dieses enthaltende pharmazeutische Zusammensetzungen
DE2534744A1 (de) Verfahren zur stabilisierung von pfanzlichen oelen, tierischen fetten und arzneimitteln auf der basis von fettloeslichen vitaminen gegen oxydativen abbau
DE2502684C2 (https=)
DE2401453A1 (de) Pharmazeutische zusammensetzung zur behandlung von hautproliferationserkrankungen
DE2302659A1 (de) Parenterales benzodiazepinhaltiges arzneimittel
DE2117762A1 (de) Behandlung von Alopecia und pharmazeutische Präparation für die Durchführung der Behandlung
DE2221281C3 (de) Pharmazeutische Zubereitungen mit entzündungshemmender und analgetischer Wirkung
DE1617812A1 (de) Verfahren zur Herstellung von endoanaesthetisch wirkenden Loesungen von Kava-Wirkstoffen
DE707580C (de) Verfahren zur Herstellung von therapeutisch wirksame Stoffe enthaltenden Emulsionen zu Injektionszwecken
DE69001540T2 (de) Arzneimittel zur rektalen verabreichung von calcitonin.

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee